Your browser doesn't support javascript.
loading
Interplay between speech and gait variables in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: A long-term instrumental assessment.
Cavallieri, Francesco; Gessani, Annalisa; Merlo, Andrea; Campanini, Isabella; Budriesi, Carla; Fioravanti, Valentina; Di Rauso, Giulia; Feletti, Alberto; Damiano, Benedetta; Scaltriti, Sara; Guagnano, Noemi; Bardi, Elisa; Corni, Maria Giulia; Antonelli, Francesca; Cavalleri, Francesca; Molinari, Maria Angela; Contardi, Sara; Menozzi, Elisa; Puzzolante, Annette; Vannozzi, Giuseppe; Bergamini, Elena; Pavesi, Giacomo; Fraix, Valérie; Meoni, Sara; Fraternali, Alessandro; Versari, Annibale; Lusuardi, Mirco; Biagini, Giuseppe; Pinto, Serge; Moro, Elena; Valzania, Franco.
Afiliação
  • Cavallieri F; Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Gessani A; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
  • Merlo A; Neurology Unit, Department of Neuroscience, S. Agostino Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Campanini I; LAM-Motion Analysis Laboratory, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, S. Sebastiano Hospital, Correggio, Italy.
  • Budriesi C; LAM-Motion Analysis Laboratory, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, S. Sebastiano Hospital, Correggio, Italy.
  • Fioravanti V; Neurology Unit, Department of Neuroscience, S. Agostino Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Di Rauso G; Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Feletti A; Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Damiano B; Neurology Unit, Department of Neuroscience, S. Agostino Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Scaltriti S; Department of Neurosciences, Biomedicine, and Movement Sciences, Institute of Neurosurgery, University of Verona, Verona, Italy.
  • Guagnano N; Neurosurgery Unit, Azienda Ospedaliero-Universitaria of Modena, Ospedale Civile Baggiovara (OCB) Hospital, Modena, Italy.
  • Bardi E; LAM-Motion Analysis Laboratory, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, S. Sebastiano Hospital, Correggio, Italy.
  • Corni MG; LAM-Motion Analysis Laboratory, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, S. Sebastiano Hospital, Correggio, Italy.
  • Antonelli F; LAM-Motion Analysis Laboratory, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, S. Sebastiano Hospital, Correggio, Italy.
  • Cavalleri F; Neurology Unit, Department of Neuroscience, S. Agostino Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Molinari MA; Neurology Unit, Department of Neuroscience, S. Agostino Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Contardi S; Neurology Unit, Department of Neuroscience, S. Agostino Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Menozzi E; Division of Neuroradiology, Department of Neuroscience, Azienda Ospedaliero-Universitaria of Modena, OCB Hospital, Modena, Italy.
  • Puzzolante A; Neurology Unit, Department of Neuroscience, S. Agostino Estense Hospital, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Vannozzi G; IRCCS Istituto delle Scienze Neurologiche di Bologna, Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna, Italy.
  • Bergamini E; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
  • Pavesi G; Neurosurgery Unit, Azienda Ospedaliero-Universitaria of Modena, Ospedale Civile Baggiovara (OCB) Hospital, Modena, Italy.
  • Fraix V; Laboratory of Bioengineering and Neuromechanics of Movement, Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.
  • Meoni S; Laboratory of Bioengineering and Neuromechanics of Movement, Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.
  • Fraternali A; Neurosurgery Unit, Azienda Ospedaliero-Universitaria of Modena, Ospedale Civile Baggiovara (OCB) Hospital, Modena, Italy.
  • Versari A; Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Neurology Department, Grenoble, France.
  • Lusuardi M; Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Neurology Department, Grenoble, France.
  • Biagini G; Nuclear Medicine Unit, Azienda Unità Sanitaria Locale IRCCS, Reggio Emilia, Italy.
  • Pinto S; Nuclear Medicine Unit, Azienda Unità Sanitaria Locale IRCCS, Reggio Emilia, Italy.
  • Moro E; Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Valzania F; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Eur J Neurol ; 30(7): 1963-1972, 2023 07.
Article em En | MEDLINE | ID: mdl-36971736
ABSTRACT

OBJECTIVE:

To evaluate correlations between speech and gait parameters in the long term and under different medication and subthalamic nucleus deep brain stimulation (STN-DBS) conditions in a cohort of advanced Parkinson's disease (PD) patients.

METHODS:

This observational study included consecutive PD patients treated with bilateral STN-DBS. Axial symptoms were evaluated using a standardized clinical-instrumental approach. Speech and gait were assessed by perceptual and acoustic analyses and by the instrumented Timed Up and Go (iTUG) test, respectively. Disease motor severity was evaluated with the total score and subscores of the Unified Parkinson's Disease Rating Scale (UPDRS) Part III. Different stimulation and drug treatment conditions were assessed on-stimulation/off-medication, off-stimulation/off-medication, and on-stimulation/on-medication.

RESULTS:

Twenty-five PD patients with a 5-year median follow-up after surgery (range 3-7 years) were included (18 males; disease duration at surgery 10.44 [SD 4.62] years; age at surgery 58.40 [SD 5.73] years). In the off-stimulation/off-medication and on-stimulation/on-medication conditions, patients who spoke louder had also the greater acceleration of the trunk during gait; whereas in the on-stimulation/on-medication condition only, patients with the poorer voice quality were also the worst to perform the sit to stand and gait phases of the iTUG. Conversely, patients with the higher speech rate performed well in the turning and walking phases of the iTUG.

CONCLUSIONS:

This study underlines the presence of different correlations between treatment effects of speech and gait parameters in PD patients treated with bilateral STN-DBS. This may allow us to better understand the common pathophysiological basis of these alterations and to develop a more specific and tailored rehabilitation approach for axial signs after surgery.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Núcleo Subtalâmico / Estimulação Encefálica Profunda Tipo de estudo: Observational_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Núcleo Subtalâmico / Estimulação Encefálica Profunda Tipo de estudo: Observational_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article